SM
GWPH

SG3 Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

SG3 Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,000
Closed -$1.23M – 1298
2020
Q3 		$1.07M Buy
+11,000
New +$1.27M 0.04% 407

Other funds holding GWPH

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG3 Management's GWPH Position: Q4 2020 in Review

SG3 Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 11,000 shares — an estimated $1.23M sold.

SG3 Management first reported a position in GWPH in Q3 2020 and held it in 1 quarter. The position peaked at $1.07M in Q3 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • SG3 Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • SG3 Management sold 11,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $1.23M.
  • SG3 Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2020 and held it in 1 quarter.
  • SG3 Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.07M in Q3 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on SG3 Management's 13F filing for Q4 2020, filed 16 Feb 2021.